NCT06993610Phase 2Active not recruiting

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-11Estimated

Enrollment · participants225Estimated

Source updated2026-06-30Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-06-30 · 1 field changed

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source

Posted 2026-02-12 · 2 fields changed

Planned enrollment increased by 45 participants

− Before

~~180 participants (planned)~~

+ After

225 participants (planned)

Primary completion date changed

− Before

~~Sep 2026~~

+ After

Nov 2026

Check registry source

Posted 2025-12-11 · 1 field changed

Planned enrollment decreased by 45 participants

− Before

~~225 participants (planned)~~

+ After

180 participants (planned)

Check registry source

Posted 2025-12-09 · 1 field changed

Planned enrollment increased by 45 participants

− Before

~~180 participants (planned)~~

+ After

225 participants (planned)

Check registry source